Cargando…
Effects of risperidone on psychotic symptoms and cognitive functions in 22q11.2 deletion syndrome: Results from a clinical trial
BACKGROUND: Carriers of the 22q11.2 deletion syndrome (22q11DS) have an enhanced risk of developing psychotic disorders. Full-blown psychosis is typically diagnosed by late adolescence/adulthood. However, cognitive decline is already apparent as early as childhood. Recent findings in mice show that...
Autores principales: | Latrèche, Caren, Maeder, Johanna, Mancini, Valentina, Schneider, Maude, Eliez, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643534/ https://www.ncbi.nlm.nih.gov/pubmed/36386982 http://dx.doi.org/10.3389/fpsyt.2022.972420 |
Ejemplares similares
-
Altered developmental trajectories of verbal learning skills in 22q11.2DS: associations with hippocampal development and psychosis
por: Latrèche, Caren, et al.
Publicado: (2023) -
Goal-Directed-Behavior in 22q11.2 Deletion Syndrome: Implication for Social Dysfunctions and the Emergence of Negative Symptoms
por: Dubourg, Lydia, et al.
Publicado: (2020) -
From Learning to Memory: A Comparison Between Verbal and Non-verbal Skills in 22q11.2 Deletion Syndrome
por: Maeder, Johanna, et al.
Publicado: (2021) -
Altered cortical thickness development in 22q11.2 deletion syndrome and association with psychotic symptoms
por: Bagautdinova, Joëlle, et al.
Publicado: (2021) -
Long-term effects of early treatment with SSRIs on cognition and brain development in individuals with 22q11.2 deletion syndrome
por: Mancini, Valentina, et al.
Publicado: (2021)